Strategy
R&D Tax Regimes update (a Cambridge Network event)
If you’re spending money on innovation such as developing new products, processes or services or enhancing existing ones, you may be eligible for R&D tax relief. Join Cambridge Network on this webinar in partnership with Deloitte to hear about this and upcoming changes to the R&...
It Takes A City needs your help
It Takes A City's Women's Homelessness Action Group are looking for a venue to pilot a much needed safe evening/overnight space for homeless/vulnerable women in Cambridge. ...
BioPartner UK appoints Strategic Communications Specialist Dr Priya Kalia to Advisory Board
BioPartner UK, the independent, accredited trade organisation, announces the appointment of Dr Priya Kalia, Managing Director of SciTribe Ltd, to its Advisory Board. BioPartner UK’s Advisory Board includes senior investors, executive and non-executive directors, and business development...
Free Webinar | How market forces impact Funds, REITS and Private Equity firms in RE
If you would like to register for this free webinar, please follow the link to our website in the blue information box on the right. ...
Free Webinar | Crafting a great Analyst CV
If you would like to register for this free webinar, please follow the link to our website in the blue information box on the right. ...
Artificial intelligence policy as a contact sport
Artificial intelligence policy as a contact sport Why bioethics and governance need to up their game in the health sector Speaker Dr Eric Meslin Book here for this free lecture incl. drinks and networking ...
Half day MS Excel 365 beginners live online training now available
Elevate your skills with this Live Online Half Day Microsoft Excel 365 course. This comprehensive 3-hour online course is designed for immediate impact and long-term retention, our training not only guides you through the intricacies of Excel 365 but also ensures you have a robust supp...
Maxion Therapeutics welcomes Dr Arndt Schottelius as new CEO
Maxion Therapeutics, the biotechnology company developing antibody-based drugs for previously untreatable ion channel- and GPCR-driven diseases, announces that Dr Arndt Schottelius has been appointed as the new Chief Executive Officer, effective on 1 March 2024, to take the Company to i...
Better Boards – a Cambridge Network webinar
Do you have a board? Should you have one? Are the right people on your board? What would make your board work better? Join Cambridge Network and Mojave Training for this webinar to examine the role boards have in your company. Boards are vital to the success of any company, no matter i...
New event for founders: Why you need an Exit Strategy now
Do you have a plan to exit your business? It’s never too early to start! Business exit strategy experts Yellowyoyo have teamed up with Innovate UK EDGE to deliver an essential event for founders that will set you on the road to maximising value, whether you plan to exit in five years or...